The Stop the Hermantown Data Center (SHDC) group held its final meeting of the year Sunday night, sharing updates on a lawsuit over a proposed 1.8 million square foot data center. The meeting ...

IBGE launches new version of the Brazilian Environmental Information Database (BDiA). The product contains the Brazilian thematic natural resource bases on a 1:250,000 scale. New version of the BDiA ...

YT Jia, Chief Advisor to AIxC Shares Weekly AIxC Investor Update: AIxC Appointed Andrew Grossman as Head of Legal Where he will Take Full Responsibility for the Company's Legal, Compliance, and ...

Trading of futures and options on the Chicago Mercantile Exchange was halted for hours on Friday, disrupting some of the world's most liquid markets for commodities and financial instruments. The ...

A long-planned refresh of the occupational data used in the disability adjudication process at the Social Security Administration was tucked inside a regulatory overhaul that the Trump administration ...

After last week’s Deer Is Hurt update, players thought the story might calm down. But when the Deer wandered into the caves, what emerged next changed everything — a glimpse of the Bat Entity, the ...

The College Board periodically updates AP® courses and exams to reflect new developments in their disciplines and more clearly communicate required content and skills. Based on feedback from the AP ...

Microsoft Corp. today is introducing updates across its database portfolio as part of general availability announcements for Azure DocumentDB and SQL Server 2025. The software and cloud giant is also ...

Three years ago, Luminal co-founder Joe Fioti was working on chip design at Intel when he came to a realization. While he was working on making the best chips he could, the more important bottleneck ...

I installed Pirate Weather about a week ago and since then I have been experiencing serious performance errors. I am getting lots of "entity took too long to update" and this seems to correlate with ...

Belenos Biosciences Inc., a private, clinical-stage biotechnology company today announced that its China partner Keymed Biosciences has reported topline results from a Phase 1b study (n=46) of BEL512 ...